SageView Advisory Group’s Theriva Biologics TOVX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-417	Closed	-$1M	–	767
2024 Q1	$1M	Buy	+417	New	+$1M	0.05%	198